Showing results (191-200 of 321) with videos related to
Sort By:
Pageof 33
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1991
Regulation of murine splenocyte responses by heparan sulfateL E Wrenshall, F B Cerra, A Carlson, et al.Transplantation|October 1, 1991
Polyreactivity and antigen specificity of human xenoreactive monoclonal and serum natural antibodiesM A Turman, P Casali, A L Notkins, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1987
Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -betaA C Ochoa, G Gromo, B J Alter, et al.Science (New York, N.Y.)|June 27, 1975
HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytesM J Sheehy, P M Sondel, M L Bach, et al.Transplantation|November 24, 1998
Regulated and endothelial cell-specific expression of Fas ligand: an in vitro model for a strategy aiming at inhibiting xenograft rejectionT H Tran, S Grey, J Anrather, et al.Transplantation|December 1, 1993
In vivo depletion of xenoreactive natural antibodies with an anti-mu monoclonal antibodyM P Soares, D Latinne, M Elsen, et al.Transplantation|November 1, 1990
Endothelial cell antigens recognized by xenoreactive human natural antibodiesJ L Platt, B J Lindman, H Chen, et al.Transplantation|March 15, 1996
Direct activation of porcine endothelial cells by human natural killer cellsD J Goodman, M Von Albertini, A Willson, et al.Cancer Research|February 15, 1989
Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsetsA C Ochoa, D E Hasz, R Rezonzew, et al.Transactions of the Association of American Physicians|January 1, 1987
Lymphokine activated killer (LAK) cell-mediated endothelial injury: a mechanism for capillary leak syndrome in patients treated with LAK cells and interleukin-2D Kotasek, G M Vercellotti, A C Ochoa, et al.Pageof 33